Alzheimer's Disease Clinical Trials
Sutter Health participates in clinical trials related to Alzheimer's Disease throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.
Title: A Randomized Double-Blinded Placebo-Controlled Exploratory Study of Intravenous Immunoglobulin (NewGam 10%) in Amnestic Mild Cognitive Impairment (Protocol IVIG-Kile-032010)Opens in a new window 
Description: This study will evaluate the efficacy of intravenous immunoglobulin in patients with Mild Cognitive Impairment for prevention or delaying progression to Alzheimer Disease Dementia over 24 months after the infusions . This study will also document brain volumetrics.
Investigator: Shawn Kile, MD
Eligibility: Age from 50 to < 85 years old. Diagnosis of Mild Cognitive Impairment, Amnestic type.
Status: Active and open to enrollment
Location: Sutter Medical Center, Sacramento
Contact: Tammy Donnel, CRC 916-453-5994 Email: Donnelt@sutterhealth.org
Title: Prediction of Cognitive Decline with MRI and MRSI
Decscription: Testing of memory functions using brain scans and neuropsycholgical tests .
Investigator: Susan Woolley, PhD
Eligibility: Subjects 60 years of age or older who have mild problems with their memory and are comfortable undergoing MRI; healthy volunteers are also needed.
Status: Active and open to enrollment
Location: California Pacific Medical Center
Contact: Dr. Woolley, PhD 415-600-1261
Email: WoolleS@sutterhealth.org
> See All Neurology Clinical Trials by Condition